Search research articles
Contact Us
Filters
Showing results (91-100 of 146) with videos related to
Page
of 15
Sort By:
Cancer
|
July 1, 1992
Scope of the problem. Indications for treatment and assessment of benign prostatic hyperplasia and its relationship to cancer
W Mebust, D Bostwick, J Grayhack, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 1, 1990
Nucleolar organizer regions in seminoma and intratubular malignant germ cells
B Delahunt, F K Mostofi, I A Sesterhenn, et al.
Der Urologe. Ausg. A
|
May 8, 1999
[Histopathologic and biological prognostic factors of clinical stage I non-seminomatous germ cell tumors. Implications for risk-adjusted therapy]
A Heidenreich, I A Sesterhenn, F K Mostofi, et al.
The Journal of Urology
|
December 22, 1999
Inflammatory infiltrate (prostatitis) in whole mounted radical prostatectomy specimens from black and white patients is not an etiology for racial difference in prostate specific antigen
W Zhang, I A Sesterhenn, R R Connelly, et al.
Cancer Treatment Reports
|
March 1, 1977
Preliminary studies of histologic prognosis in cancer of the prostate
M Harada, F K Mostofi, D K Corle, et al.
Fertility and Sterility
|
July 1, 1994
The effect of testicular nongerm cell tumors on local spermatogenesis
G T Ho, H Gardner, K Mostofi, et al.
Urology
|
April 1, 1997
Incidence and clinical significance of high-grade prostatic intraepithelial neoplasia in TURP specimens
P B Gaudin, I A Sesterhenn, K J Wojno, et al.
JAMA
|
January 18, 1980
Pathology in the Soviet Union
F K Mostofi, M J Williams, W H Hartmann, et al.
The American Journal of Surgical Pathology
|
November 15, 2000
A distinctive myointimal proliferation ('myointimoma') involving the corpus spongiosum of the glans penis: a clinicopathologic and immunohistochemical analysis of 10 cases
J F Fetsch, R W Brinsko, C J Davis, et al.
The Journal of Urology
|
October 1, 1994
Proliferating cell nuclear antigen expression to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors
E B Fernandez, I A Sesterhenn, W F McCarthy, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 146) with videos related to
Sort By:
Page
of 15
Cancer
|
July 1, 1992
Scope of the problem. Indications for treatment and assessment of benign prostatic hyperplasia and its relationship to cancer
W Mebust, D Bostwick, J Grayhack, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 1, 1990
Nucleolar organizer regions in seminoma and intratubular malignant germ cells
B Delahunt, F K Mostofi, I A Sesterhenn, et al.
Der Urologe. Ausg. A
|
May 8, 1999
[Histopathologic and biological prognostic factors of clinical stage I non-seminomatous germ cell tumors. Implications for risk-adjusted therapy]
A Heidenreich, I A Sesterhenn, F K Mostofi, et al.
The Journal of Urology
|
December 22, 1999
Inflammatory infiltrate (prostatitis) in whole mounted radical prostatectomy specimens from black and white patients is not an etiology for racial difference in prostate specific antigen
W Zhang, I A Sesterhenn, R R Connelly, et al.
Cancer Treatment Reports
|
March 1, 1977
Preliminary studies of histologic prognosis in cancer of the prostate
M Harada, F K Mostofi, D K Corle, et al.
Fertility and Sterility
|
July 1, 1994
The effect of testicular nongerm cell tumors on local spermatogenesis
G T Ho, H Gardner, K Mostofi, et al.
Urology
|
April 1, 1997
Incidence and clinical significance of high-grade prostatic intraepithelial neoplasia in TURP specimens
P B Gaudin, I A Sesterhenn, K J Wojno, et al.
JAMA
|
January 18, 1980
Pathology in the Soviet Union
F K Mostofi, M J Williams, W H Hartmann, et al.
The American Journal of Surgical Pathology
|
November 15, 2000
A distinctive myointimal proliferation ('myointimoma') involving the corpus spongiosum of the glans penis: a clinicopathologic and immunohistochemical analysis of 10 cases
J F Fetsch, R W Brinsko, C J Davis, et al.
The Journal of Urology
|
October 1, 1994
Proliferating cell nuclear antigen expression to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors
E B Fernandez, I A Sesterhenn, W F McCarthy, et al.
Page
of 15